Savara SVRA
NASDAQ SVRA
$4.99 +0.07 (+1.42%)
At close: Nov 11, 2026 · 4:00 PM EST

Savara (SVRA) Preferred Stock Liabilities (2014 - 2016)

Updated

Savara (SVRA) posted Preferred Stock Liabilities of $43.86 million for Q4 2016, up 2.0% from $42.99 million a year earlier.

Analysis

Savara (SVRA) Preferred Stock Liabilities (2014 - 2016) Analysis & Trends

  • In prior years, Savara's Preferred Stock Liabilities was $42.99 million in FY2015 (+112.1%) and $20.27 million in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Savara 1.09 Bn 407.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 43.86 Mn
Sep 30, 2016 10,000.00
Jun 30, 2016 11,000.00
Dec 31, 2015 42.99 Mn
Dec 31, 2014 20.27 Mn
API Access

Savara Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=SVRA&period=max&api_key=YOUR_API_KEY